Stopping Cancer

We are making progress stopping cancer through research. We hear about new drugs and therapies on a regular basis, but we have a long way to go. Lung, prostate and colon-rectal cancers are the most dangerous in men, and lung, breast and colon-rectal cancers are the most dangerous for women, according to the American Cancer Society.

Fortunately, thanks to past research, most people diagnosed with cancer survive at least 5 years, although the survival stats vary widely by the type of cancer. Death rates from most forms of cancer are on the decline. The following graphs from the American Cancer Society are fascinating, but they show we can do better (click on the images to enlarge).

We can help move these numbers down even faster by supporting ongoing research into cancer and cancer treatments. That is exactly what the companies who are participating in my special RxTrace ad program in support of cancer research are doing. These special ads can be found in the right sidebar of RxTrace. Each of these companies have paid to have their ads placed on RxTrace in this special program through September, and I have pledged to donate 100% of their payment to fund cancer research at the James Cancer Hospital and Solove Research Institute at the Ohio State University through the Pelotonia organization.

Please reach out to these companies and thank them for their generosity in supporting such important work. If you would like to add your company to this list, it is not too late! Please contact me for details.

Related

Post navigation

RxTrace Recommends

About The Author

Dirk is a Regulatory Strategist with Systech International and founder of RxTrace. He has contributed to many of the industry groups that have been formed over the last 10 years to investigate solutions to the problem of counterfeit and other illegitimate drugs in the legitimate supply chain. He served as co-chair of a number of key technical work groups in GS1 and GS1 US. These include the original GS1 EPCglobal Drug Pedigree Messaging work group that created the DPMS pedigree standard, the Network Centric ePedigree (NCeP) work group and the RFID Barcode Interoperability Guideline work group. Dirk holds a BS in Electrical and Computer Engineering from the University of Wisconsin-Madison.

DISCLAIMER: RxTrace contains some of the personal thoughts, ideas and opinions of Dirk Rodgers. The material contained in RxTrace is not legal advice. Dirk Rodgers is not a lawyer.The reader must make their own decisions about the accuracy of the opinions expressed in RxTrace. Readers are encouraged to consult their own legal counseland trading partners before taking any actions based on information found in RxTrace. RxTrace is not a vehicle for communicatingthe positions of any company, organization or individual other than Dirk Rodgers.